As a shareholder of Pfizer (PFE) or Mylan N.V. (MYL), we wanted to provide an update on your holdings. Pfizer recently completed a spin-off of it's Upjohn business, combining it with Mylan N.V. to form a new entity, Viatris, which began trading on 11/16/2020 under the ticker symbol VTRS. Mylan N.V. was delisted from the Nasdaq stock exchange as a result of this corporate action and is no longer tradeable.
For shareholders who held Pfizer (PFE) shares on or before 11/13/2020
Pfizer shareholders who held PFE shares on or before 11/13/2020 received 0.124079 shares of VTRS for every PFE share they held at the close of the market on 11/13/2020. Fractional shareholders received VTRS shares proportional to their holdings of PFE.
In addition, Pfizer shareholders will still own the same amount of PFE shares after this corporate action.
The distribution of shares outlined above will be reflected in your Cash App Investing portfolio upon the company's completion of its distribution to shareholders.
For shareholders who held Mylan N.V. (MYL) on or before it’s merger with Upjohn on 11/16/2020
As a result of its merger with Pfizer’s Upjohn to form Viatris, Inc. (VTRS), Mylan N.V. (MYL) was delisted from the Nasdaq stock exchange on 11/17/2020. Shareholders of MYL received 1 share of VTRS for every 1 share of MYL they held at the close of market on 11/16/2020. Fractional shareholders received VTRS shares proportional to their holdings of MYL.
If you have questions regarding this corporate action, you may be able to contact the company’s Investor Relations team, or visit the Investor Relations page on their website for more information.
Investing involves risk; you may lose money. Brokerage services provided by Cash App Investing LLC, member FINRA/SIPC and a subsidiary of Square, Inc. Past performance of a security or financial product does not guarantee future results or returns. You should consider the risks before investing. For more on the risks of investing see our Disclosure Library.
What this means for shareholders